MENS (Jyong Biotech) Construction In Progress: $0.14 Mil (As of Dec. 2025)


MENS Jyong Biotech Ltd MENS
10 GF Score
Price $2.22
! 3 Warning Signs
View Full Analysis

What is Jyong Biotech Construction In Progress?

Jyong Biotech MENS +6.47% 10 Construction In Progress is $0.14 Mil as of Dec. 2025. GuruFocus rates MENS with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Jyong Biotech's quarterly construction in progress declined from Dec. 2024 ($0.14 Mil) to Jun. 2025 ($0.00 Mil) but then increased from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($0.14 Mil).

Jyong Biotech's annual construction in progress declined from Dec. 2023 ($0.14 Mil) to Dec. 2024 ($0.14 Mil) but then increased from Dec. 2024 ($0.14 Mil) to Dec. 2025 ($0.14 Mil).

Jyong Biotech Construction In Progress Historical Data

* Premium members only.

The historical data trend for Jyong Biotech's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jyong Biotech Construction In Progress Chart

Jyong Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
0.03 0.14 0.14 0.14 0.14

Jyong Biotech Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial 0.14 0.14 0.14 0.00 0.14
MENS
10GF Score
Jyong Biotech Ltd MENS
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jyong Biotech Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0.14 Mil mean?
Jyong Biotech (MENS) has a Construction In Progress of $0.14 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Jyong Biotech and its competitors.
Is Jyong Biotech's Construction In Progress too high?
Jyong Biotech's current Construction In Progress is $0.14 Mil. Overall, Jyong Biotech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Jyong Biotech's Construction In Progress compare to ENLV and CNTB?
Jyong Biotech's Construction In Progress of $0.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Jyong Biotech and its competitors. Jyong Biotech's current Construction In Progress is $0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jyong Biotech stock overvalued right now?
Jyong Biotech (MENS) has a current Construction In Progress of $0.14 Mil. The current Construction In Progress is $0.14 Mil. Jyong Biotech's overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Jyong Biotech (MENS), the current Construction In Progress is $0.14 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jyong Biotech Business Description

Address Xintai 5th Road, 23F-3, No. 95, Section 1, Xizhi district, New Taipei, TWN, 221
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
10GF Score

Get the complete analysis for MENS

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.22
Price